Showing results (501-510 of 671) with videos related to

Sort By:
Pageof 68
Cancer Research|May 18, 2021
The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem CellsPrashant V Bommi, Charles M Bowen, Laura Reyes-Uribe, et al.
International Journal of Molecular Sciences|August 26, 2022
A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune ResponseEhsan Irajizad, Johannes F Fahrmann, James P Long, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib TreatmentRunzhe Chen, Won-Chul Lee, Junya Fujimoto, et al.
Advances in Radiation Oncology|November 24, 2022
Evolutionary Action Score of <i>TP53</i> Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234Chieko Michikawa, Pedro A Torres-Saavedra, Natalie L Silver, et al.
IEEE Life Sciences Letters|March 24, 2021
SCT Promoter Methylation is a Highly Discriminative Biomarker for Lung and Many Other CancersAdwait Sathe, Yu-An Zhang, Xiaotu Ma, et al.
Cancer|January 4, 2023
Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohortWilliam N William, Jianjun Zhang, Xin Zhao, et al.
Science Signaling|March 5, 2024
eEF1A2 promotes PTEN-GSK3β-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancerWarapen Treekitkarnmongkol, Luisa M Solis, Deivendran Sankaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2022
Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer InterceptionSharia Hernandez, Edwin Roger Parra, Naohiro Uraoka, et al.
JCI Insight|August 10, 2018
Requirement for MUC5AC in KRAS-dependent lung carcinogenesisAlison K Bauer, Misha Umer, Vanessa L Richardson, et al.
The Journal of Biological Chemistry|January 28, 2015
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancerFernanda I Staquicini, Ming D Qian, Ahmad Salameh, et al.
Pageof 68